Viewing Protocol Section

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section

Study NCT00096239
Ignite Creation Date: 2024-05-05 @ 11:39 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00096239
Protocol Section: NCT00096239
Start Identification Module Data
Expand Identification Module Data
Brief Title: CP-547632 in Treating Patients With Recurrent or Persistent Ovarian Cancer Primary Peritoneal Cancer or Fallopian Tube Cancer
Official Title: Phase II Open-Label Multi-Center Study of CP-547 632 an Oral Tyrosine Kinase Inhibitor of VEGFR-2 in Subjects With Recurrent or Persistent Small-Volume Epithelial Ovarian Cancer Primary Peritoneal Serous Cancer or Fallopian Tube Cancer
Acronym: None
Organization: National Cancer Institute NCI
Organization Class: NIH
Organization Study ID: CDR0000390237
Secondary IDs
Secondary ID Type Domain Link
UCLA-0311057-01 None None None
PFIZER-A3521003 None None None
Start Status Module Data
Status Verified Date: 2005-02
Overall Status: COMPLETED
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Jonsson Comprehensive Cancer Center
Lead Sponsor Class: OTHER
Lead Sponsor: Jonsson Comprehensive Cancer Center
Start Oversight Module Data No Oversight Module Defined
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload